Search
Affymetrix CytoScan Dx Assay
FDA-approval Jan 2014 [1]
Procedure:
- assay analyzes a patient's entire genome using a single blood sample
- can detect both large & small variations in regions of the genome linked to intellectual & developmental disabilities
General
DNA microarray (gene chip)
References
- FDA News Release: Jan. 17, 2014
FDA allows marketing for first of-its-kind post-natal test to
help diagnose developmental delays and intellectual
disabilities in children.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm382179.htm